Clinical Trial: SWOG S2108CD

SWOG S2108CD

Status: Closed

A Cluster Randomized Trial Comparing An Educationally Enhanced Genomic Tumor Board (EGTB) Intervention to Usual Practice to Increase Evidence-Based Genome-Informed Therapy

Limited site participation.  Open only to Kootenai Cancer Center.

S2108CD is permanently closed to new patient accrual, effective November 22, 2024, at 12:00 p.m. Pacific Time.